Division of Rheumatology, Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Graduate Program in Immunology, University of Michigan, Ann Arbor, Michigan, USA.
Ann Rheum Dis. 2022 Oct;81(10):1428-1437. doi: 10.1136/annrheumdis-2022-222656. Epub 2022 Jun 16.
Lupus T cells demonstrate aberrant DNA methylation patterns dominated by hypomethylation of interferon-regulated genes. The objective of this study was to identify additional lupus-associated DNA methylation changes and determine the genetic contribution to epigenetic changes characteristic of lupus.
Genome-wide DNA methylation was assessed in naïve CD4 T cells from 74 patients with lupus and 74 age-matched, sex-matched and race-matched healthy controls. We applied a trend deviation analysis approach, comparing methylation data in our cohort with over 16 500 samples. Methylation quantitative trait loci (meQTL) analysis was performed by integrating methylation profiles with genome-wide genotyping data.
In addition to the previously reported epigenetic signature in interferon-regulated genes, we observed hypomethylation in the promoter region of the miR-17-92 cluster in patients with lupus. Members of this microRNA cluster play an important role in regulating T cell proliferation and differentiation. Expression of two microRNAs in this cluster, miR-19b1 and miR-18a, showed a significant positive correlation with lupus disease activity. Among miR-18a target genes, , which encodes a negative regulator of nuclear factor kappa B, was downregulated in lupus CD4 T cells. MeQTL identified in lupus patients showed overlap with genetic risk loci for lupus, including and . The lupus risk allele in (rs1131665) was associated with significant hypomethylation. However, <1% of differentially methylated CpG sites in patients with lupus were associated with an meQTL, suggesting minimal genetic contribution to lupus-associated epigenotypes.
The lupus defining epigenetic signature, characterised by robust hypomethylation of interferon-regulated genes, does not appear to be determined by genetic factors. Hypomethylation of the miR-17-92 cluster that plays an important role in T cell activation is a novel epigenetic locus for lupus.
狼疮 T 细胞表现出异常的 DNA 甲基化模式,以干扰素调节基因的低甲基化为主。本研究的目的是确定其他与狼疮相关的 DNA 甲基化变化,并确定遗传因素对狼疮特征性的表观遗传变化的贡献。
对 74 例狼疮患者和 74 名年龄、性别和种族匹配的健康对照者的幼稚 CD4 T 细胞进行全基因组 DNA 甲基化评估。我们应用趋势偏差分析方法,将我们队列中的甲基化数据与超过 16500 个样本进行比较。通过整合甲基化谱与全基因组基因分型数据,进行甲基化数量性状基因座(meQTL)分析。
除了先前报道的干扰素调节基因的表观遗传特征外,我们还观察到狼疮患者 miR-17-92 簇启动子区域的低甲基化。该 microRNA 簇的成员在调节 T 细胞增殖和分化中发挥重要作用。该簇中的两个 microRNA,miR-19b1 和 miR-18a 的表达与狼疮疾病活动度呈显著正相关。在 miR-18a 的靶基因中,编码核因子 kappa B 负调节剂的 ,在狼疮 CD4 T 细胞中下调。狼疮患者中的 meQTL 与狼疮的遗传风险位点重叠,包括 和 。位于 (rs1131665)的狼疮风险等位基因与显著的 低甲基化相关。然而,狼疮患者中差异甲基化 CpG 位点中仅有不到 1%与 meQTL 相关,表明遗传因素对狼疮相关表型的影响很小。
以干扰素调节基因的强低甲基化为特征的狼疮定义性表观遗传特征似乎不是由遗传因素决定的。在 T 细胞激活中起重要作用的 miR-17-92 簇的低甲基化是狼疮的一个新的表观遗传位点。